Tankyrase Inhibition Attenuates Cardiac Dilatation and Dysfunction in Ischemic Heart Failure
Authors:
- Hong WangHWHong Wang
- Heli SegersvärdHSHeli Segersvärd
- Juuso SirenJSJuuso Siren
- Sanni PerttunenSPSanni Perttunen
- Katariina ImmonenKIKatariina Immonen
- Riikka KosonenRKRiikka Kosonen
- Yu-Chia ChenYCYu-Chia Chen
- Johanna TolvaJTJohanna Tolva
- Mirjami LaivuoriMLMirjami Laivuori
- Mikko I. MäyränpääMMMikko I. Mäyränpää
- Petri T. KovanenPKPetri T. Kovanen
- Juha SinisaloJSJuha Sinisalo
Open Access
- 2 September 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (17) , 10059
Abstract
Hyperactive poly(ADP-ribose) polymerases (PARP) promote ischemic heart failure (IHF) after myocardial infarction (MI). However, the role of tankyrases (TNKSs), members of the PARP family, in pathogenesis of IHF remains unknown. We investigated the expression and activation of TNKSs in myocardium of IHF patients and MI rats. We explored the cardioprotective effect of TNKS inhibition in an isoproterenol-induced zebrafish HF model. In IHF patients, we observed elevated TNKS2 and DICER and concomitant upregulation of miR-34a-5p and miR-21-5p in non-infarcted myocardium. In a rat MI model, we found augmented TNKS2 and DICER in the border and infarct areas at the early stage of post-MI. We also observed consistently increased TNKS1 in the border and infarct areas and destabilized AXIN in the infarct area from 4 weeks onward, which in turn triggered Wnt/β-catenin signaling. In an isoproterenol-induced HF zebrafish model, inhibition of TNKS activity with XAV939, a TNKSs-specific inhibitor, protected against ventricular dilatation and cardiac dysfunction and abrogated overactivation of Wnt/β-catenin signaling and dysregulation of miR-34a-5p induced by isoproterenol. Our study unravels a potential role of TNKSs in the pathogenesis of IHF by regulating Wnt/β-catenin signaling and possibly modulating miRNAs and highlights the pharmacotherapeutic potential of TNKS inhibition for prevention of IHF.Keywords
Funding Information
- Suomen Kulttuurirahasto
- Sydäntutkimussäätiö
- The Aarne Koskelo Foundation
- Finska Läkaresällskapet
- Finnish Foundation for Laboratory Medicine
- Liv och Hälsa Foundation
- Suomen kliinisen kemian yhdistys
- Suomen Lääketieteen Säätiö
- Finnish state funding for university-level research
- Helsingin Yliopisto
This publication has 62 references indexed in Scilit:
- An Anthelmintic Drug, Pyrvinium Pamoate, Thwarts Fibrosis and Ameliorates Myocardial Contractile Dysfunction in a Mouse Model of Myocardial InfarctionPLOS ONE, 2013
- mir-17–92 Cluster Is Required for and Sufficient to Induce Cardiomyocyte Proliferation in Postnatal and Adult HeartsCirculation Research, 2013
- MicroRNA-34a regulates cardiac ageing and functionNature, 2013
- Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitorsNature Biotechnology, 2012
- Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repairThe EMBO Journal, 2011
- Capture of MicroRNA–Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor SignalingPLOS Genetics, 2011
- Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transitionDisease Models & Mechanisms, 2011
- Genetic variants in eleven telomere-associated genes and the risk of incident cardio/cerebrovascular disease: The Women's Genome Health StudyClinica Chimica Acta, 2011
- Active Wnt signaling in response to cardiac injuryBasic Research in Cardiology, 2010
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signallingNature, 2009